These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 15752213

  • 1. Dehydroepiandosterone induction of increased resistance to vancomycin in Staphylococcus aureus clinical isolates (MSSA, MRSA).
    Plotkin BJ, Morejon A, Laddaga RA, Viselli SM, Tjhio J, Schreckenberger P.
    Lett Appl Microbiol; 2005; 40(4):249-54. PubMed ID: 15752213
    [Abstract] [Full Text] [Related]

  • 2. Possible role of sarA in dehydroepiandrosterone-mediated increase in Staphylococcus aureus resistance to vancomycin.
    Plotkin BJ, Konaklieva M.
    Chemotherapy; 2007; 53(3):181-4. PubMed ID: 17356267
    [Abstract] [Full Text] [Related]

  • 3. Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage.
    Alós JI, García-Cañas A, García-Hierro P, Rodríguez-Salvanés F.
    J Antimicrob Chemother; 2008 Oct; 62(4):773-5. PubMed ID: 18552338
    [Abstract] [Full Text] [Related]

  • 4. Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates.
    Hussain FM, Boyle-Vavra S, Shete PB, Daum RS.
    J Infect Dis; 2002 Sep 01; 186(5):661-7. PubMed ID: 12195353
    [Abstract] [Full Text] [Related]

  • 5. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia.
    Sakoulas G, Gold HS, Cohen RA, Venkataraman L, Moellering RC, Eliopoulos GM.
    J Antimicrob Chemother; 2006 Apr 01; 57(4):699-704. PubMed ID: 16464892
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro exposure of community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains to vancomycin: does vancomycin resistance occur?
    Kleinschmidt SL, Munckhof WJ, Nimmo GR.
    Int J Antimicrob Agents; 2006 Feb 01; 27(2):168-70. PubMed ID: 16420976
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterisation of laboratory-generated vancomycin intermediate resistant Staphylococcus aureus strains.
    Bhateja P, Purnapatre K, Dube S, Fatma T, Rattan A.
    Int J Antimicrob Agents; 2006 Mar 01; 27(3):201-11. PubMed ID: 16417988
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Investigation of glycopeptide resistance in methicillin resistant staphylococcal isolates].
    Hoşgör Limoncu M, Ermertcan S, Taşli H, Kurutepe S.
    Mikrobiyol Bul; 2007 Oct 01; 41(4):511-6. PubMed ID: 18173069
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative proteomics analyses reveal a potential biomarker for the detection of vancomycin-intermediate Staphylococcus aureus strains.
    Drummelsmith J, Winstall E, Bergeron MG, Poirier GG, Ouellette M.
    J Proteome Res; 2007 Dec 01; 6(12):4690-702. PubMed ID: 17997515
    [Abstract] [Full Text] [Related]

  • 19. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
    Appelbaum PC.
    Int J Antimicrob Agents; 2007 Nov 01; 30(5):398-408. PubMed ID: 17888634
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.